Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Supreme Cannabis Company Inc. (The) T.FIRE

The Supreme Cannabis Co Inc is a Canada-based company engaged in the production and sale of medical and recreational cannabis. Its portfolio includes products that address recreational, medical, and wellness consumers. Its brands include BlissCo, Truverra, 7ACRES, Sugarleaf, and Hiway.


TSX:FIRE - Post by User

Post by johnaleon Sep 18, 2019 10:08pm
259 Views
Post# 30141749

GMP Equity Research - 3.25 target BUY

GMP Equity Research - 3.25 target BUY

The Supreme Cannabis Company1,6

FIRE-TSX

September 18, 2019

Nice Q4/FY19 EBITDA beat, outlook remains solid

FIRE reported Q4/FY19 results yesterday that beat profitability expectations. Q4 sales were pre-released and thus in-line but were up an impressive 91% QoQ, at $19m. Adj. EBITDA however came in at $3.2m, well-above our street-high forecast of $1.5m and consensus of $0.8m, driven by higher than expected gross margin.

Impressive production scale efficiencies. FIRE achieved its highest gross margin on record in Q4/FY19 at 64%, up a surprising 1,400bps QoQ, and higher than our 50% forecast. This was not driven by pricing as management indicated its average dry flower prices were roughly stable YoY, and rather explained by significant production scale efficiencies. During the quarter, FIRE increased its capacity by ~90% with 23 total licensed flowering rooms and 230,000 sq.ft. of cultivation space. We also believe FIRE’s profitability benefitted from a right-sizing of its employee base, initiatives to improve yields taking hold, and the realization of some efficiencies from automation.

Pathway to Cannabis 2.0 products. We expect FIRE to continue ramping up its premium flower and pre-roll offering while also introducing more proprietary strains going forward. However, we expect FIRE could take a more measured approach to infrastructure development to manufacture its own Cannabis 2.0 products. To this end, we expect FIRE to continue to utilize contract manufacturers in coming quarters, accelerating its time to market for vape and concentrate products and leveraging its relationship with PAX and KKE to capture market share. As demand trends for extractproducts evolve, we would expect this to guide managements’ capital allocationstrategy with respect to deploying its own extract capacity with a view towards maximizing its margins and ROIC over the medium term.

FY20 guidance reiterated. Management maintained confidence in FIRE’s stronggrowth outlook by reiterating its FY20 guidance, calling for revenues of $150180m.That said, the company’s margin profile could have some lumpiness in the comingquarters. We expect a ramp up in S&M expenses to support the launch of Cannabis 2.0 products, combined with greater reliance on contract manufacturing partners, ahead of FIRE’s own extraction capacity coming online later in FY20 with the Truverra acquisition. As a result, we expect FY20 EBITDA could be more back-half weighted.

Maintaining $3.25 target; BUY. With strong Q4/FY19 results and meaningful positive EBITDA for the first time, in our view, FIRE has joined the relatively exclusive club of profitable Canadian LPs, which we believe argues for stronger valuation metrics. In addition, despite Q4/FY19’s strong top line growth, we note FIRE ended the quarter with its highest inventory position on record, up more than 2.5x QoQ to $19m. This should provide good support for future revenue growth and flexibility for inventory allocation towards Cannabis 2.0 products. Our target is based on a DCF using: 1) a 9.5%

discount rate, 2) avg. market share of ~8%, and 3) 3% terminal growth.


<< Previous
Bullboard Posts
Next >>

USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse